- Investing Ideas
- /
- Peruvian Pharmaceuticals & Biotech Potentially Undervalued Companies
Peruvian Pharmaceuticals & Biotech Potentially Undervalued Companies
Results
6
1 new
Companies with a Value score of at least 3, ordered by Value score
6 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
MRK | US$85.52 | -10.9% | -27.7% | US$210.0b | US$119.90 | PE12.3x | E7.8% | 3.9% | ||
PFE | US$26.60 | 0% | -4.6% | US$144.7b | US$32.48 | PE18x | E3.6% | 6.7% | ||
BMY | US$58.75 | 0% | 18.9% | US$109.4b | US$66.75 | PS2.3x | E34.4% | 4.6% | ||
REGN | US$680.10 | -36.0% | n/a | US$72.1b | US$938.34 | PE16.3x | E10.3% | 0.5% | ||
GILD | US$90.55 | 0% | 19.4% | US$129.7b | US$91.15 | PE270.2x | E23.5% | 3.0% | ||
TMO New | US$607.50 | 0% | 9.9% | US$203.4b | US$758.54 | PE32.1x | E10.6% | 0.3% |
Page 1 of 1